[{"address1": "Robert Koch Strasse 50", "city": "Mainz", "zip": "55129", "country": "Germany", "phone": "49 6131 554 2860", "website": "https://mainzbiomed.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Mr. Guido  Baechler", "age": 58, "title": "CEO & Executive Director", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William J. Caragol", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Von Torne P.M.P., Ph.D.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Krieg-Schneider", "age": 61, "title": "Chief Technology Officer", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Moritz  Eidens Ph.D.", "age": 39, "title": "Chief Science Officer & Executive Director", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Stefan  Erlach", "title": "Head of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philipp  Freese", "age": 40, "title": "Chief Business Officer", "yearBorn": 1983, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2583, "open": 0.27, "dayLow": 0.2301, "dayHigh": 0.27, "regularMarketPreviousClose": 0.2583, "regularMarketOpen": 0.27, "regularMarketDayLow": 0.2301, "regularMarketDayHigh": 0.27, "beta": 0.12, "forwardPE": -0.33243245, "volume": 1821832, "regularMarketVolume": 1821832, "averageVolume": 1836930, "averageVolume10days": 2007320, "averageDailyVolume10Day": 2007320, "bid": 0.2383, "ask": 0.249, "bidSize": 100, "askSize": 200, "marketCap": 5384103, "fiftyTwoWeekLow": 0.185, "fiftyTwoWeekHigh": 3.392, "priceToSalesTrailing12Months": 6.01254, "fiftyDayAverage": 0.32436, "twoHundredDayAverage": 0.721075, "currency": "USD", "enterpriseValue": 5733952, "floatShares": 18389100, "sharesOutstanding": 21886600, "sharesShort": 720638, "sharesShortPriorMonth": 324522, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.032899998, "heldPercentInsiders": 0.21632999, "heldPercentInstitutions": 0.00472, "shortRatio": 0.39, "shortPercentOfFloat": 0.0392, "impliedSharesOutstanding": 21886600, "bookValue": 0.154, "priceToBook": 1.5974027, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -26295728, "trailingEps": -1.62, "forwardEps": -0.74, "enterpriseToRevenue": 6.403, "enterpriseToEbitda": -0.22, "52WeekChange": -0.9130742, "SandP52WeekChange": 0.34083736, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MYNZ", "underlyingSymbol": "MYNZ", "shortName": "Mainz Biomed N.V.", "longName": "Mainz Biomed N.V.", "firstTradeDateEpochUtc": 1636119000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "74995154-4535-3bd7-9d98-8548f3c030bf", "messageBoardId": "finmb_1679642292", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.246, "targetHighPrice": 2.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.0, "targetMedianPrice": 2.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 7070925, "totalCashPerShare": 0.323, "ebitda": -26074670, "totalDebt": 7420780, "quickRatio": 0.804, "currentRatio": 0.972, "totalRevenue": 895479, "debtToEquity": 228.386, "revenuePerShare": 0.055, "returnOnAssets": -0.93424004, "returnOnEquity": -3.03203, "freeCashflow": -13606395, "operatingCashflow": -21938844, "revenueGrowth": 0.111, "grossMargins": 0.56915003, "operatingMargins": -30.687128, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]